Consolidation Systemic Therapy in Locally Advanced, Inoperable Nonsmall Cell Lung Cancer—How to Identify Patients Which Can Benefit from It?

Background: Consolidation systemic therapy (ST) given after concurrent radiotherapy (RT) and ST (RT-ST) is frequently practiced in locally advanced inoperable nonsmall cell lung cancer (NSCLC). Little is known, however, about the fate of patients achieving different responses after concurrent phases...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeremić, Branislav, Mariamidze, Elene, Shoshiashvili, Inga, Kiladze, Ivane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689287/
https://www.ncbi.nlm.nih.gov/pubmed/36354716
http://dx.doi.org/10.3390/curroncol29110656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689287/
https://www.ncbi.nlm.nih.gov/pubmed/36354716
http://dx.doi.org/10.3390/curroncol29110656

Ejemplares similares